keyword
MENU ▼
Read by QxMD icon Read
search

Mirena

keyword
https://www.readbyqxmd.com/read/27871920/integrating-long-acting-reversible-contraception-larc-services-into-new-york-city-school-based-health-centers-sbhcs-quality-improvement-to-ensure-provision-of-youth-friendly-services
#1
Manaswi Sangraula, Samantha Garbers, Janet Garth, Emily Birchfield Shakibnia, Sarah Timmons, Melanie A Gold
STUDY OBJECTIVE: Adolescents face barriers to accessing youth-friendly family planning services, specifically long-acting reversible contraception (LARC). School-Based Health Centers (SBHCs) can provide youth-friendly care. A quality improvement (QI) project was undertaken to assess quality of care before, during and after LARC services at three SBHCs, and to identify specific strategies for improving these LARC services. METHODS: We interviewed 18 female adolescents who received LARC services...
November 18, 2016: Journal of Pediatric and Adolescent Gynecology
https://www.readbyqxmd.com/read/27743678/chlamydia-trachomatis-re-infection-in-spain-a-sti-clinic-based-cohort-study
#2
Josefina López-de-Munain, Maria Del Mar Cámara-Pérez, Manuel Imaz-Pérez, Javier Pereda-Berroeta, Iñigo López-Azcarreta, Josefa Muñoz-Sánchez, Ramón Cisterna-Cáncer, Oscar Luis Ferrero-Beneitez, Sofia Ibarra-Ugarte, Zuriñe Zubero-Sulibarria, Josu Mirena Baraia-Etxaburu Artetxe
BACKGROUND: Chlamydia trachomatis (C. trachomatis) is the most frequently reported sexually transmitted infection (STI) in developed countries, but there is a lack data on its incidence and population dynamics in Spain. The objectives of this study were to estimate the incidence of C. trachomatis in patients seeking medical attention in an STI clinic with a defined population catchment area, to identify factors associated with this infection, and to explore differences between factors associated with new infections and re-infections...
October 13, 2016: Enfermedades Infecciosas y Microbiología Clínica
https://www.readbyqxmd.com/read/27678781/hysteroscopic-removal-of-malpositioned-mirena-iud-embedded-in-cesarean-scar-niche
#3
R Sangha, S Talukdar
No abstract text is available yet for this article.
November 2015: Journal of Minimally Invasive Gynecology
https://www.readbyqxmd.com/read/27597909/bleeding-versus-clotting-a-complex-case-of-a-large-fibroid-uterus-causing-menorrhagia-and-a-dvt
#4
Sangeeta Ramanan, Jude Chapman-Wardy, Roy Watson
A 43-year-old woman presented with severe anaemia secondary to menorrhagia. Pelvic ultrasound showed a large intramural posterior fundal fibroid. Hysteroscopy showed the fibroid distorting the endometrial cavity, precluding Mirena® device insertion. As she was initially hesitant to have a hysterectomy, medical management with the oral contraceptive pill (OCP) and tranexamic acid was instituted, with good effect. Months later, after a long road trip, she presented with left leg swelling, and a Doppler ultrasound confirmed an extensive deep vein thrombosis (DVT)...
2016: Case Reports in Obstetrics and Gynecology
https://www.readbyqxmd.com/read/27554014/two-week-postpartum-intrauterine-contraception-insertion-a-study-of-feasibility-patient-acceptability-and-short-term-outcomes
#5
Matthew L Zerden, Gretchen S Stuart, Samantha Charm, Amy Bryant, Joanne Garrett, Jessica Morse
OBJECTIVE: To determine the feasibility and acceptability of inserting the levonorgestrel intrauterine system, LNG 52 mg IUS (LNG IUS), at 2 weeks postpartum. STUDY DESIGN: This prospective study of feasibility and patient acceptability recruited women interested in a postpartum LNG IUS and placed the LNG IUS under ultrasound guidance on days 14-20 postpartum. We determined feasibility by our ability to recruit and insert the LNG IUS in our predetermined sample size of 50 women...
January 2017: Contraception
https://www.readbyqxmd.com/read/27549429/retrospective-analysis-of-the-impact-of-increasing-access-to-long-acting-reversible-contraceptives-in-a-commercially-insured-population
#6
Amy Law, Dominic Pilon, Richard Lynen, François Laliberté, Laurence Gozalo, Patrick Lefebvre, Mei Sheng Duh
BACKGROUND: Unintended pregnancies have been shown to be associated with high costs for the healthcare system, among other adverse impacts, but could still account for up to 51 % of pregnancies in the US. Improvements in contraception among women are needed. Long acting reversible contraceptives (LARCs), which have proved their safety and efficacy, have been found to significantly decrease the risk of unintended pregnancy. Yet they are still marginally employed. This study aims at investigating the evolution of LARC use over 15 years and at assessing the impact of the introduction of newer LARCs on LARC use relative to all contraceptive use...
2016: Reproductive Health
https://www.readbyqxmd.com/read/27524103/short-versus-long-duration-levofloxacin-plus-rifampicin-for-acute-staphylococcal-prosthetic-joint-infection-managed-with-implant-retention-a-randomised-clinical-trial
#7
Jaime Lora-Tamayo, Gorane Euba, Javier Cobo, Juan Pablo Horcajada, Alex Soriano, Enrique Sandoval, Carles Pigrau, Natividad Benito, Luis Falgueras, Julián Palomino, María Dolores Del Toro, Alfredo Jover-Sáenz, José Antonio Iribarren, Mar Sánchez-Somolinos, Antonio Ramos, Marta Fernández-Sampedro, Melchor Riera, Josu Mirena Baraia-Etxaburu, Javier Ariza
Levofloxacin plus rifampicin (L+R) is the treatment of choice for acute staphylococcal prosthetic joint infection (PJI) managed with debridement and implant retention (DAIR). Long courses have been empirically recommended, but some studies have suggested that shorter treatments could be as effective. Our aim was to prove that a short treatment schedule was non-inferior to the standard long schedule. An open-label, multicentre, randomised clinical trial (RCT) was performed. Patients with an early post-surgical or haematogenous staphylococcal PJI, managed with DAIR and initiated on L+R were randomised to receive 8 weeks of treatment (short schedule) versus a long schedule (3 months or 6 months for hip or knee prostheses, respectively)...
September 2016: International Journal of Antimicrobial Agents
https://www.readbyqxmd.com/read/27187927/the-use-of-long-acting-reversible-contraceptives-and-the-relationship-between-discontinuation-rates-due-to-menopause-and-to-female-and-male-sterilizations
#8
Jessica Mayra Ferreira, Ilza Monteiro, Sara Castro, Marina Villarroel, Carolina Silveira, Luis Bahamondes
Introduction Women require effective contraception until they reach menopause. The long acting reversible contraceptives (LARC) and the depot-medroxyprogesterone acetate (DMPA, Depo-Provera®, Pfizer, Puurs, Belgium) are great options and can replace possible sterilizations. Purpose To assess the relationship between the use of LARCs and DMPA and terminations ascribed to menopause and sterilizations in a Brazilian clinic. Methods We reviewed the records of women between 12 and 50 years of age attending the clinic that chose to use a LARC method or DMPA...
May 2016: Revista Brasileira de Ginecologia e Obstetrícia
https://www.readbyqxmd.com/read/27181408/time-trends-in-the-aetiology-of-prosthetic-joint-infections-a-multicentre-cohort-study
#9
N Benito, M Franco, A Ribera, A Soriano, D Rodriguez-Pardo, L Sorlí, G Fresco, M Fernández-Sampedro, M Dolores Del Toro, L Guío, E Sánchez-Rivas, A Bahamonde, M Riera, J Esteban, J M Baraia-Etxaburu, J Martínez-Alvarez, A Jover-Sáenz, C Dueñas, A Ramos, B Sobrino, G Euba, L Morata, C Pigrau, P Coll, I Mur, J Ariza
It is important to know the spectrum of the microbial aetiology of prosthetic joint infections (PJIs) to guide empiric treatment and establish antimicrobial prophylaxis in joint replacements. There are no available data based on large contemporary patient cohorts. We sought to characterize the causative pathogens of PJIs and to evaluate trends in the microbial aetiology. We hypothesized that the frequency of antimicrobial-resistant organisms in PJIs has increased in the recent years. We performed a cohort study in 19 hospitals in Spain, from 2003 to 2012...
August 2016: Clinical Microbiology and Infection
https://www.readbyqxmd.com/read/27179741/corrigendum-to-the-brazilian-cardioprotective-nutritional-program-to-reduce-events-and-risk-factors-in-secondary-prevention-for-cardiovascular-disease-study-protocol-the-balance-program-trial-american-heart-journal-171-1-2016-73-81
#10
Bernardete Weber, Ângela C Bersch-Ferreira, Camila R Torreglosa, Maria B Ross-Fernandes, Jacqueline T da Silva, Andrea P Galante, Enilda de Sousa Lara, Rosana P Costa, Rafael M Soares, Alexandre B Cavalcanti, Emilio H Moriguchi, Neide M Bruscato, Josiele Kesties, Lilian Vivian, Marina Schumacher, Waldemar de Carli, Luciano M Backes, Bruna R Reolão, Milena P Rodrigues, Dúnnia M B Baldissera, Glaucia S Tres, Hugo R K Lisbôa, João B J Bem, Jose B C Reolão, Keyla L A L Deucher, Maiara Cantarelli, Aline Lucion, Daniela Rampazzo, Vanessa Bertoni, Rosileide S Torres, Adriana O L Verríssimo, Aldair S Guterres, Andrea F R Cardos, Dalva B S Coutinho, Mayara G Negrão, Mônica F A Alencar, Priscila M Pinho, Socorro N A A Barbosa, Ana P P F Carvalho, Maria I S Taboada, Sheila A Pereira, Raul V Heyde, Francisca E Z Nagano, Rebecca Baumgartner, Fernanda P Resende, Ranata Tabalipa, Ana C Zanini, Michael J R Machado, Hevila Araujo, Maria L V Teixeira, Gabriela C Souza, Priccila Zuchinali, Bianca M Fracasso, Karen Ulliam, Marina Schumacher, Moara Pierotto, Thamires Hilário, Daniele M O Carlos, Cintia G N C Cordeiro, Daniele A Carvalho, Marília S Gonçalves, Valdiana B Vasconcelos, Rosa Bosquetti, Raira Pagano, Marcelo L P Romano, César A Jardim, Bernardo N A de Abreu, Aline Marcadenti, Alessandra R Schmitt, Angela M V Tavares, Christiane C Faria, Flávia M Silva, Jaqueline S Fink, Raquel M El Kik, Clarice F Prates, Cristiane S Vieira, Elaine F Adorne, Ellen H Magedanz, Fernanda L Chieza, Ingrid S Silva, Joise M Teixeira, Eduardo P Trescastro, Lívia A Pellegrini, Jéssika C Pinto, Cristina T Telles, Antonio C S Sousa, Andreza S Almeida, Ariane A Costa, José A C Carmo, Juliana T Silva, Luciana V S Alves, Saulo O C Sales, Maria E M Ramos, Marilia C S Lucas, Monica Damiani, Patricia C Cardoso, Salvador S Ramos, Clenise F Dantas, Amanda G Lopes, Ana M P Cabral, Ana C A Lucena, Auriene L Medeiros, Bernardino B Terceiro, Neuma M F S Leda, Sandra R D Baía, Josilene M F Pinheiro, Alexandra N Cassiano, Andressa N L Melo, Anny K O Cavalcanti, Camila V S Souza, Dayanna J M Queiroz, Hercilla N C F Farias, Larissa C F Souza, Letícia S Santos, Luana R M Lima, Meg S Hoffmann, Átala S Silva Ribeiro, Daniel F Vasconcelos, Eliane S Dutra, Marina K Ito, José A F Neto, Alexsandro F Santos, Rosângela M L Sousa, Luciana Pereira P Dias, Maria T M A Lima, Victor G Modanesi, Adriana F Teixeira, Luciana C N C D Estrada, Paulo V G Modanesi, Adriana B L Gomes, Bárbara R S Rocha, Cristina Teti, Marta M David, Bruna M Palácio, Délcio G S Junior, Érica H S Faria, Michelle C F Oliveira, Rose M Uehara, Sandramara Sasso, Annie S B Moreira, Ana C A H Cadinha, Carla W M Pinto, Mariana P Castilhos, Mariana Costa, Cristiane Kovacs, Daniel Magnoni, Quênia Silva, Michele F C A Germini, Renata A da Silva, Aline S Monteiro, Karina G Dos Santos, Priscila Moreira, Fernanda C Amparo, Catharina C J Paiva, Soraia Poloni, Diana S Russo, Izabele V Silveira, Maria A Moraes, Mirena Boklis, Quinto I Cardoso, Annie S B Moreira, Aline M S Damaceno, Elisa M Santos, Glauber M Dias, Cláudia P S Pinho, Adrilene C Cavalcanti, Amanda S Bezerra, Andrey V Queiroga, Isa G Rodrigues, Tallita V Leal, Viviane Sahade, Daniele A Amaral, Diana S Souza, Givaldo A Araújo, Karine Curvello, Manuella Heine, Marília M S Barretto, Nailson A Reis, Sandra M L Vasconcelos, Danielly C Vieira, Francisco A Costa, Jessica M S Fontes, Juvenal G C Neto, Laís N P Navarro, Raphaela C Ferreira, Patrícia M Marinho, Renata Torres Abib, Aline Longo, Eduardo G Bertoldi, Lauren S Ferreira, Lúcia R Borges, Norlai A Azevedo, Celma M Martins, Juliana T Kato, Maria C O Izar, Marina T Asoo, Mariana D de Capitani, Valéria A Machado, Waléria T Fonzar, Sônia L Pinto, Kellen C Silva, Lúcia H A Gratão, Sheila D Machado, Susane R U de Oliveira, Josefina Bressan, Ana P S Caldas, Hatanne C F M Lima, Helen H M Hermsdorff, Tânia M Saldanha, Sílvia E Priore, Naoel H Feres, Adila de Queiroz Neves, Loanda M G Cheim, Nilma F Silva, Silvia R L Reis, Andreza M Penafort, Ana Paula O de Queirós, Geysa M N Farias, Mônica L P de Los Santos, Cíntia L Ambrozio, Cirília N Camejo, Cristiano P Dos Santos, Gabriela S Schirmann, Jorge L Boemo, Rosane E C Oliveira, Súsi M B Lima, Vera M S Bortolini, Cristina H Matos, Claiza Barretta, Clarice M Specht, Simone R de Souza, Cristina S Arruda, Priscila A Rodrigues, Otávio Berwanger
No abstract text is available yet for this article.
May 2016: American Heart Journal
https://www.readbyqxmd.com/read/27172400/declining-rates-of-sterilization-procedures-in-western-australian-women-from-1990-to-2008-the-relationship-with-age-hospital-type-and-government-policy-changes
#11
Khadra A Jama-Alol, Alexandra P Bremner, Louise M Stewart, Anna Kemp-Casey, Eva Malacova, Rachael Moorin, Adeleh Shirangi, David B Preen
OBJECTIVE: To describe trends in age-specific incidence rates of female sterilization (FS) procedures in Western Australia and to evaluate the effects of the introduction of government-subsidized contraceptive methods and the implementation of the Australian government's baby bonus policy on FS rates. DESIGN: Population-based retrospective descriptive study. SETTING: Not applicable. PATIENT(S): All women ages 15-49 undergoing an FS procedure during the period January 1, 1990, to December 31, 2008 (n = 47,360 procedures)...
September 1, 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/26769874/patient-or-clinician-duration-of-use-of-intrauterine-devices-based-on-who-initiated-discussion-of-placement
#12
Tammy Chang, Michelle H Moniz, Melissa A Plegue, Kathryn Sage Shaffer, Heather B Vance, Katherine J Gold
BACKGROUND: Although safe and effective, intrauterine devices (IUDs) are underutilized in the United States. The objective of this study was to determine whether patient- and clinician-initiated discussions were associated with the duration of Mirena (52 mg levonorgestrel-releasing) IUD use. METHODS: Retrospective chart review identified Mirena IUDs that were placed and removed for reasons other than the desire for pregnancy from January 1, 2005, to January 1, 2012, at 1 academic center (n = 148)...
January 2016: Journal of the American Board of Family Medicine: JABFM
https://www.readbyqxmd.com/read/26672176/-contraception-during-the-perimenopause-indications-security-and-non-contraceptive-benefits
#13
P Cantero Pérez, J Klingemann, M Yaron, N Fournet Irion, I Streuli
Although patients' fertility is diminished in the period of perimenopause, they still need efficient contraception. Thorough knowledge of the physiological changes occuring during this period of transition is essential in order to provide optimal care. Until the age of 50, no contraceptive method is specifically considered unsuitable due to age alone. The choice of contraceptive needs to be adapted to the patient, assessing the individual risk factors and favouring the potential non-contraceptive advantages of the method selected...
October 28, 2015: Revue Médicale Suisse
https://www.readbyqxmd.com/read/26630538/relapse-risk-of-endometrial-hyperplasia-after-treatment-with-the-levonorgestrel-impregnated-intrauterine-system-or-oral-progestogens
#14
A Ørbo, M Arnes, A B Vereide, B Straume
OBJECTIVE: To investigate relapse rates after the successful treatment of patients with non-atypical endometrial hyperplasia who were randomised to either a levonorgestrel-impregnated intrauterine system (LNG-IUS; Mirena(®) ) or two regimens of oral medroxyprogesterone acetate (MPA) after primary histological response. DESIGN: A multicentre randomised trial. SETTING: Ten different outpatient clinics localised in hospitals and seven gynaecological private practices in Norway...
August 2016: BJOG: An International Journal of Obstetrics and Gynaecology
https://www.readbyqxmd.com/read/26626534/long-acting-hormonal-contraception
#15
REVIEW
Giuseppe Benagiano, Henry Gabelnick, Ivo Brosens
Today, a new category of fertility-regulating agents has been created: long-acting, reversible hormonal contraceptives; they minimize compliance, while maximize effectiveness. They comprise subdermal implants and intrauterine devices. Other long-acting agents exist, such as Depo Provera and Noristerat. Use of Depo Provera and Noristerat carries great effectiveness, good clinical safety and usefulness in developing countries. They cause no significant increase in breast cancer risk, but they may carry an increased risk of HIV...
November 2015: Women's Health
https://www.readbyqxmd.com/read/26507206/a-randomised-controlled-trial-of-the-clinical-effectiveness-and-cost-effectiveness-of-the-levonorgestrel-releasing-intrauterine-system-in-primary-care-against-standard-treatment-for-menorrhagia-the-eclipse-trial
#16
RANDOMIZED CONTROLLED TRIAL
Janesh K Gupta, Jane P Daniels, Lee J Middleton, Helen M Pattison, Gail Prileszky, Tracy E Roberts, Sabina Sanghera, Pelham Barton, Richard Gray, Joe Kai
BACKGROUND: Heavy menstrual bleeding (HMB) is a common problem, yet evidence to inform decisions about initial medical treatment is limited. OBJECTIVES: To assess the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) (Mirena®, Bayer) compared with usual medical treatment, with exploration of women's perspectives on treatment. DESIGN: A pragmatic, multicentre randomised trial with an economic evaluation and a longitudinal qualitative study...
October 2015: Health Technology Assessment: HTA
https://www.readbyqxmd.com/read/26240745/risk-of-intracranial-hypertension-with-intrauterine-levonorgestrel
#17
Mahyar Etminan, Hao Luo, Paul Gustafson
OBJECTIVES: The objective of this study was to quantify the risk of intracranial hypertension (ICH) with the intrauterine levonorgestrel (IUL) device Mirena(®). METHODS: We used the United States Food and Drug Administration's Adverse Events Reporting System (FAERS) database to quantify a reporting odds ratio (ROR) for ICH and Mirena(®). We also conducted a retrospective cohort study using the IMS LifeLink(®) database, comparing the risk of two oral contraceptives ethinyl estradiol (EE) with Mirena(®)...
June 2015: Therapeutic Advances in Drug Safety
https://www.readbyqxmd.com/read/26117991/-levonorgestrel-releasing-intrauterine-system-mirena%C3%A2-bayer-for-the-prevention-and-treatment-of-endometrial-adenocarcinoma-and-the-incidence-of-other-malignancies-in-women
#18
REVIEW
Maciej Jóźwik, Marcin Jóźwik, Beata Modzelewska, Marta Niewińska, Michał Jóźwik
The use of hormone-releasing intrauterine devices has been on the increase for the last three decades. To date, evidence of their long-term efficiency is available. The aim of the present paper was to briefly review beneficial prophylactic effects of the levonorgestrel-releasing intrauterine system on the incidence of a variety of malignancies in women. Such an influence is of a particular importance in the light of the currently observed increased prevalence of endometrial and cervical adenocarcinomas. Low-dose releasing intrauterine systems are also available, but the hard evidence-based medical data have been derived primarily for Mirena® (Bayer) device, which topically releases from 20 to 14 pg of levonorgestrel daily...
April 2015: Ginekologia Polska
https://www.readbyqxmd.com/read/25988513/the-new-lng-releasing-ius-a-new-opportunity-to-reduce-the-burden-of-unintended-pregnancy
#19
REVIEW
Ignacio Cristobal, José-Luis Neyro, Iñaki Lete
Unintended pregnancies still remain a worldwide public health problem. They have received much attention in adolescents given the strong impact they have on their present and future lives. Young women wishing to delay maternity are also especially vulnerable to unintended pregnancies. Studies have revealed a pattern of use of contraceptive methods that is likely to increase this risk. Methods of long-acting reversible contraception (LARC), among which copper and levonorgestrel-releasing intrauterine devices (IUD and IUS) are the most common, have been widely recommended to avoid unintended pregnancy at any age...
July 2015: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://www.readbyqxmd.com/read/25950126/fertility-sparing-treatment-of-early-endometrial-cancer-and-complex-atypical-hyperplasia-in-young-women-of-childbearing-potential
#20
Stanislav Mikhailovich Pronin, Olga Valerievna Novikova, Julia Yurievna Andreeva, Elena Grigorievna Novikova
OBJECTIVE: To evaluate oncologic and reproductive outcome with levonorgestrel-releasing intrauterine system combined with gonadotropin-releasing hormone agonist in women with grade 1 endometrial carcinoma, and the levonorgestrel monotherapy in women with complex atypical hyperplasia. MATERIALS/METHODS: A prospective study was conducted. We analyzed the clinical characteristics of 70 patients younger than 42 years (mean age, 33 years) with a diagnosis of complex atypical endometrial hyperplasia (AEH) or grade 1 endometrial adenocarcinoma who were treated with hormonal therapy at the Division of Gynecologic Oncology of P...
July 2015: International Journal of Gynecological Cancer
keyword
keyword
18901
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"